Literature DB >> 29166591

A CD103+ Conventional Dendritic Cell Surveillance System Prevents Development of Overt Heart Failure during Subclinical Viral Myocarditis.

Xavier Clemente-Casares1, Siyavash Hosseinzadeh2, Iulia Barbu3, Sarah A Dick1, Jillian A Macklin2, Yiming Wang1, Abdul Momen1, Crystal Kantores1, Laura Aronoff2, Maylis Farno4, Tiffany M Lucas5, Joan Avery5, Dorrin Zarrin-Khat6, Heidi J Elsaesser7, Babak Razani5, Kory J Lavine5, Mansoor Husain8, David G Brooks9, Clinton S Robbins10, Myron Cybulsky2, Slava Epelman11.   

Abstract

Innate and adaptive immune cells modulate heart failure pathogenesis during viral myocarditis, yet their identities and functions remain poorly defined. We utilized a combination of genetic fate mapping, parabiotic, transcriptional, and functional analyses and demonstrated that the heart contained two major conventional dendritic cell (cDC) subsets, CD103+ and CD11b+, which differentially relied on local proliferation and precursor recruitment to maintain their tissue residency. Following viral infection of the myocardium, cDCs accumulated in the heart coincident with monocyte infiltration and loss of resident reparative embryonic-derived cardiac macrophages. cDC depletion abrogated antigen-specific CD8+ T cell proliferative expansion, transforming subclinical cardiac injury to overt heart failure. These effects were mediated by CD103+ cDCs, which are dependent on the transcription factor BATF3 for their development. Collectively, our findings identified resident cardiac cDC subsets, defined their origins, and revealed an essential role for CD103+ cDCs in antigen-specific T cell responses during subclinical viral myocarditis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cells; dendritic cells; heart failure; myocarditis; ontogeny; virus

Mesh:

Substances:

Year:  2017        PMID: 29166591     DOI: 10.1016/j.immuni.2017.10.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  20 in total

1.  Isolation and Identification of Extravascular Immune Cells of the Heart.

Authors:  Laura Aronoff; Slava Epelman; Xavier Clemente-Casares
Journal:  J Vis Exp       Date:  2018-08-23       Impact factor: 1.355

2.  Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction.

Authors:  Florian Leuschner; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2020-03-01       Impact factor: 29.983

Review 3.  Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair.

Authors:  William P Lafuse; Daniel J Wozniak; Murugesan V S Rajaram
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

4.  FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.

Authors:  Thomas E Bickett; Michael Knitz; Laurel B Darragh; Shilpa Bhatia; Benjamin Van Court; Jacob Gadwa; Shiv Bhuvane; Miles Piper; Diemmy Nguyen; Hua Tu; Laurel Lenz; Eric T Clambey; Kevin Barry; Sana D Karam
Journal:  Clin Cancer Res       Date:  2021-09-13       Impact factor: 12.531

Review 5.  A cardioimmunologist's toolkit: genetic tools to dissect immune cells in cardiac disease.

Authors:  Anthony Wong; Homaira Hamidzada; Slava Epelman
Journal:  Nat Rev Cardiol       Date:  2022-05-06       Impact factor: 32.419

6.  Myeloid Cells Remodel the Mitral Valve.

Authors:  Sebastian Cremer; Matthias Nahrendorf
Journal:  Circulation       Date:  2018-06-05       Impact factor: 29.690

7.  Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.

Authors:  Gyu Seong Heo; Benjamin Kopecky; Deborah Sultan; Monica Ou; Guoshuai Feng; Geetika Bajpai; Xiaohui Zhang; Hannah Luehmann; Lisa Detering; Yi Su; Florian Leuschner; Christophe Combadière; Daniel Kreisel; Robert J Gropler; Steven L Brody; Yongjian Liu; Kory J Lavine
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 8.  The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).

Authors:  Kory J Lavine; Alexander R Pinto; Slava Epelman; Benjamin J Kopecky; Xavier Clemente-Casares; James Godwin; Nadia Rosenthal; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

Review 9.  High-density lipoprotein-mediated cardioprotection in heart failure.

Authors:  Ampadu O Jackson; Jun Meng; Huifang Tang; Kai Yin
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

Review 10.  Electroimmunology and cardiac arrhythmia.

Authors:  Jana Grune; Masahiro Yamazoe; Matthias Nahrendorf
Journal:  Nat Rev Cardiol       Date:  2021-03-02       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.